Repligen opens new bioprocessing training center in the Netherlands

21 april 2026
Repligen Corporation has opened a new Training & Innovation Center in Breda, expanding its global support network for bioprocessing customers. The facility is located at its OPUS® pre-packed chromatography column manufacturing site and is designed to give users hands-on experience with the company’s technologies.

The new center—called the Repligen Training & Innovation Center (RTIC)—focuses on real-world application. It includes demonstration areas, product displays, and space for workshops. Customers can use the site for both pre-sales evaluation and post-sales training, helping teams better understand how to implement and optimize Repligen’s solutions in their own processes.

Part of a growing global network

The Breda facility is Repligen’s third RTIC, joining existing centers in Waltham and Tokyo. The company says this expansion reflects a broader strategy to stay close to customers and provide regional technical support.
At the opening event on April 15, biopharma companies and CDMOs were invited to explore the facility and its capabilities.

Showcasing upstream to downstream solutions

One of the key features of the Breda RTIC is that it brings together technologies from across Repligen’s portfolio in a single location. According to the company, the site enables customers to evaluate process technologies and equipment used in biologics manufacturing, including filtration, chromatography, fluid management, and process analytical tools.

Supporting end-to-end process development

According to Repligen’s leadership, the goal of the RTIC is not just to display products, but to support end-to-end process development. By combining training, technical support, and a full technology suite in one place, the company aims to help bioprocessing teams improve efficiency, scalability, and implementation speed.
Overall, the Breda center strengthens Repligen’s ability to provide localized, hands-on support—something increasingly important as bioprocessing becomes more complex and globally distributed.

Bron: Repligen